Jan 17, 2023 / 10:00PM GMT
Operator
Thank you for standing by, and welcome to the Telix Pharmaceuticals Limited Q4 2022 Financial Results Presentation and Shareholder Update. (Operator Instructions) I would now like to hand the conference over to Ms. Kyahn Williamson, SVP of Investor Relations and Corporate Communications. Please go ahead.
Kyahn Williamson - Telix Pharmaceuticals Limited - SVP of Corporate Communications & IR
Well, good morning, everybody, and welcome to our investor call today. We appreciate you taking the time to tune in. We'll be discussing the Appendix 4C cash flow report and activities report lodged on the ASX today. I'm joined by Dr. Christian Behrenbruch, our Group CEO and Managing Director; and Darren Smith, our Group Chief Financial Officer.
We will be taking you through some slides today. For those who are on the webcast, they should be in full view. And for those on the phone, we'll give you a verbal queue to let you know which slide we're up to, and then we'll move to Q&A at the end.
So just starting from Slide 5. So before we kick off, I
Q4 2022 Telix Pharmaceuticals Ltd Activities Report Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers